- Peter T Scardino MD Florence and Theodore Baumritter/Enid Ancell Chair, Chairman, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY
- W. M Linehan MD Chief, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
- Michael J Zelefsky MD
- Nicholas J Vogelzang MD Director, Nevada Cancer Institute, Las Vegas, NV
- Brian I Rini MD
- Bernard H Bochner MD
- Joel Sheinfeld MD
Comprehensive Textbook of Genitourinary Oncology was the first major textbook to focus on the field of genitourinary oncology from the combined perspectives of the molecular biologist, pathologist, oncologist and urologist. The first edition of the book had three fundamental goals: 1) to be a textbook that could be read and used by practicing physicians, 2) to be an authoritative textbook for basic scientists, 3) to be an effective interpretation of this field for trainees in surgery, medical and radiation oncology, and pathology. The goals for the 4th edition remain essentially the same. The book takes a systems approach to this field, with sections on prostate, bladder, kidney, testis, and penile cancers, as well as one each on pediatric and other (less common) malignancies. This volume will introduce and distill the combined knowledge and expertise of specialist from a multitude of scientific and clinical disciplines who are internationally recognized leaders in their fields and who themselves have contributed to the field. As in the last edition, authors will be drawn form the fields of urological surgery, medical oncology, radiation oncology, pathology, radiology as well as translational scientists and epidemiologists.
- NEW! Covers merging image-guided targeted technologies such as magnetic resonance image-guided high-intensity focused ultrasound, which can precisely ablate cancerous cells without damage to surrounding healthy tissue.
- NEW! Greater focus on the multidisciplinary care of patients with urological cancers with improved outcomes dependent on collaborative development of care plans that incorporate evidence-based management.
- NEW! Includes new imaging modalities including diffusion-weighted imaging and magnetic resonance spectroscopic imaging which help clinicians differentiate tumor subtypes and target treatment
- NEW! Increase coverage of molecular classification of cancers and the delineation of critical pathways that can identify new targets for systemic therapy and demonstrate how cells react to particular drugs.
- NEW! Reviews combined imaging technology, such as MR-ultrasound fusion to better guide needle biopsies, and PET-CT imaging to identify and locate biologically active metastatic lesions, as well as novel radiotracers highly specific for key molecules present in
- NEW! Summarize and evaluate the latest research on existing and investigational new drugs.
- Most comprehensive GU cancer book on the market
- Editors represent each of the major sub areas in this field (Vogelzang/medical oncology, Scardino/urology (prostate), Zelefsky/radiation oncology, and Linehan/urology (kidney)
- Multi-modality approach of the book reflects the way in which these cancers are managed and encourages multidisciplinary sales opportunities